Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA4 | P22748 | 2/20 | 0.41 |
| ▸ | CA5A | P35218 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
| ▸ | CFTR | P13569 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | MGLL | Q99685 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | GAA | P10253 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ALPG | P10696 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6827880 | 0.78 | KCNH2 (0.47) | KCNH2CA2CA4CA5ACA12 | |
| SCHEMBL6684937 | 0.78 | KCNH2 (0.47) | KCNH2CA2CA4CA5ACA12 | |
| SCHEMBL10710925 | 0.76 | KCNH2 (0.45) | KCNH2CA2CA4CA5ACA12 | |
| SCHEMBL3077639 | 0.74 | KCNH2 (0.44) | KCNH2CA2CA4CA5ACA12 | |
| SCHEMBL5351835 | 0.74 | KCNH2 (0.44) | KCNH2CA2CA4CA5ACA12 | |
| SCHEMBL3081826 | 0.73 | ESR1 (0.37) | KCNH2CA2CA4CA5ACA12 | |
| SCHEMBL6831537 | 0.73 | CA2 (0.52) | KCNH2CA2CA4CA5ACA12 | |
| SCHEMBL1883203 | 0.72 | KCNH2 (0.61) | KCNH2CA2CA4CA5ACA12 | |
| SCHEMBL4926345 | 0.69 | CA2 (0.52) | CA2CA4CA5ACFTRMAPT | |
| SCHEMBL11174295 | 0.69 | CA2 (0.52) | CA2CA4CA5ACFTRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12365763-B2 | Phthalonitrile resins, methods of making same and compositions thereof | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC | 2025-07-22 | — | — | US | disclosed |
| CN-115175950-B | Curable compositions of benzoxazine and phthalonitrile resins | 亨斯迈先进材料美国有限责任公司 | 2025-01-28 | — | — | CN | disclosed |
| US-20230023657-A1 | Phthalonitrile Resins, Methods Of Making Same And Compositions Thereof | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC | 2023-01-26 | — | — | US | disclosed |
| US-20220403108-A1 | Curable Compositions Of Benzoxazine And Phthalonitrile Resins | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC | 2022-12-22 | — | — | US | disclosed |
| EP-4051727-A1 | PHTHALONITRILE RESINS, METHODS OF MAKING SAME AND COMPOSITIONS THEREOF | Huntsman Advanced Materials Americas LLC (US) | 2022-09-07 | — | — | EP | disclosed |
| EP-4051726-A1 | CURABLE COMPOSITIONS OF BENZOXAZINE AND PHTHALONITRILE RESINS | Huntsman Advanced Materials Americas LLC (US) | 2022-09-07 | — | — | EP | disclosed |
| WO-2021087193-A1 | PHTHALONITRILE RESINS, METHODS OF MAKING SAME AND COMPOSITIONS THEREOF | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC (US) | 2021-05-06 | — | — | WO | disclosed |
| WO-2021087197-A1 | CURABLE COMPOSITIONS OF BENZOXAZINE AND PHTHALONITRILE RESINS | HUNTSMAN ADVANCED MATERIALS AMERICAS LLC (US) | 2021-05-06 | — | — | WO | disclosed |
| US-8530607-B2 | Aromatic ether and alkynyl containing phthalonitriles | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2013-09-10 | — | — | US | disclosed |
| US-8524750-B2 | (Pyrazol-3-yl)-1,3,4-thiadiazol-2-amine and (pyrazol-3-yl)-1,3,4-thiazol-2-amine compounds | GLAXO GROUP LIMITED (GB) | 2013-09-03 | — | — | US | disclosed |
| US-6891014-B2 | Oligomeric hydroxy arylether phthalonitiles and synthesis thereof | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2005-05-10 | — | — | US | disclosed |
| EP-1507816-A1 | OLIGOMERIC HYDROXY ARYLETHER PHTHALONITILES AND SYNTHESIS THEREOF | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE NAVY (US) | 2005-02-23 | — | — | EP | disclosed |
| US-20040181029-A1 | Oligomeric hydroxy arylether phthalonitiles and synthesis thereof | UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY, THE | 2004-09-16 | — | — | US | disclosed |
| US-20040181027-A1 | Oligomeric hydroxy arylether phthalonitiles and synthesis thereof | NAVY, THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE | 2004-09-16 | — | — | US | disclosed |
| US-20040181028-A1 | Oligomeric hydroxy arylether phthalonitiles and synthesis thereof | NAVY, THE, UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE | 2004-09-16 | — | — | US | disclosed |
| US-6756470-B2 | Oligomeric hydroxy arylether phthalonitiles and synthesis thereof | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY | 2004-06-29 | — | — | US | disclosed |
| US-20030229198-A1 | Oligomeric hydroxy arylether phthalonitiles and synthesis thereof | NAVY, UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF, THE | 2003-12-11 | — | — | US | disclosed |
| WO-2003091312-A1 | OLIGOMERIC HYDROXY ARYLETHER PHTHALONITILES AND SYNTHESIS THEREOF | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRSENTED BY THE SECRETARY OF THE NAVY (US) | 2003-11-06 | — | — | WO | disclosed |
| WO-2003060192-A1 | NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| US-5247060-A | Curing phthalonitriles with acid | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1993-09-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12365763-B2 | Phthalonitrile resins, methods of making same and compositions thereof | PNN, PAH, CUL4B | KCNH2 3599/4885CA2 2617/4885CA4 1442/4885 |
| US-20230023657-A1 | Phthalonitrile Resins, Methods Of Making Same And Compositions Thereof | PNN, PAH, CUL4B | KCNH2 3599/4885CA2 2617/4885CA4 1442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.